DBV Technologies (DBVT) Revenue (2020 - 2026)
DBV Technologies (DBVT) reported Revenue of $700000.0 for Q2 2026, down 53.33% on a YoY basis from $1.5 million in Q2 2025, and down 22.22% sequentially from $900000.0 in Q1 2026.
DBV Technologies (DBVT) Revenue (2020 - 2026) Analysis & Trends
DBV Technologies (DBVT) has 7 years of Revenue data on file, last reported at $700000.0 in Q2 2026.
- For the quarter ending Q2 2026, Revenue fell 53.33% year-over-year to $700000.0; the trailing twelve-month figure through Jun 2026 stood at $5.0 million (up 27.64% YoY), and the FY2025 full-year result was $5.6 million, up 34.19% from the prior year.
- Revenue retreated to $700000.0 in Q2 2026, from $900000.0 in the prior quarter.
- In the past five years, Revenue ranged from a high of $8.9 million in Q4 2023 to a low of -$1.3 million in Q4 2022.
- A 5-year average of $1.8 million and a median of $1.5 million in 2024 frame the typical range for Revenue.
- Across the five-year window, Revenue tumbled 144.47% in 2022 and soared 780.6% in 2023, its largest moves.
- Tracing DBVT's Revenue over 5 years: stood at -$1.3 million in 2022, then soared by 780.6% to $8.9 million in 2023, then tumbled by 93.69% to $560000.0 in 2024, then increased by 15.18% to $645000.0 in 2025, then advanced by 8.53% to $700000.0 in 2026.
- Business Quant data shows DBVT's Revenue at $700000.0 in Q2 2026, $900000.0 in Q1 2026, and $645000.0 in Q4 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Revenue (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 67,072.09 Bn | 67,072.09 Bn | - | - |
| 2 | Nanobiotix | 1,894.61 Bn | 1,894.55 Bn | - | - |
| 3 | Akari Therapeutics | 1,014.18 Bn | 1,014.18 Bn | - | - |
| 4 | BeOne Medicines | 471.64 Bn | 466.85 Bn | 1.35 Bn | 1.51 Bn |
| 5 | Vertex Pharmaceuticals | 121.72 Bn | 114.47 Bn | 2.59 Bn | 2.99 Bn |
| 6 | Regeneron Pharmaceuticals | 68.28 Bn | 59.52 Bn | 3.31 Bn | 3.61 Bn |
| 7 | Belite Bio | 61.40 Bn | 61.40 Bn | - | - |
| 8 | Argenx Se | 56.94 Bn | 56.94 Bn | 1.18 Bn | 1.30 Bn |
| 9 | Revolution Medicines | 37.37 Bn | 37.37 Bn | - | - |
| 10 | DBV Technologies | 5.88 Bn | 5.71 Bn | - | 700,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 700,000.00 |
| Mar 31, 2026 | 900,000.00 |
| Dec 31, 2025 | 645,000.00 |
| Sep 30, 2025 | 2.77 Mn |
| Jun 30, 2025 | 1.50 Mn |
| Mar 31, 2025 | 800,000.00 |
| Dec 31, 2024 | 560,000.00 |
| Sep 30, 2024 | 1.07 Mn |
| Jun 30, 2024 | 1.16 Mn |
| Mar 31, 2024 | 1.41 Mn |
| Dec 31, 2023 | 8.88 Mn |
| Sep 30, 2023 | 2.37 Mn |
| Jun 30, 2023 | 2.29 Mn |
| Mar 31, 2023 | 2.19 Mn |
| Dec 31, 2022 | -1.30 Mn |
| Sep 30, 2022 | 2.07 Mn |
| Jun 30, 2022 | 1.53 Mn |
| Mar 31, 2022 | 2.55 Mn |
| Dec 31, 2021 | 2.93 Mn |
| Sep 30, 2021 | 1.32 Mn |